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In approaching the treatment of obesity, three major
caveats, specific to this complex disease, need to be taken
into consideration in order to avoid over-simplification.
Firstly, obesity definition is currently based on the body
mass index (BMI). However, BMI has two major limita-
tions: it is not a measure of fat mass, and it does not convey
any information on fat distribution and regional fat depots.
These limitations are well known by the scientific com-
munity that is struggling to find ways to move beyond BMI
in obesity classification.
Secondly, for the reasons specified above, the develop-
ment of comorbidities or complications, which occur in the
vast majority of obese patients during the course of the
disease, is not always linearly correlated with BMI. Many
variables contribute to their manifestation beyond the
degree of obesity: duration of disease, age, sex, fat distri-
bution, genetic background, the degree of mechanical dis-
ability, etc.
Thirdly, treatment options are now quite few. Their
indications should take into account the severity of obesity
together with the presence and severity of complications
and age, in order to grade interventions; these varying from
therapeutic lifestyle changes to bariatric surgery.
In order to provide a staging system able to help clini-
cians in phenotyping obese patients, beyond BMI, Sharma
and Kushner [1] developed the so-called EOSS (Edmonton
Obesity Staging System) composed of the following five
stages:
0. No apparent obesity-related risk factors (e.g., blood
pressure, serum lipids, fasting glucose, etc., within
normal range), no physical symptoms, no psy-
chopathology, no functional limitations and/or impair-
ment of well-being.
1. Presence of obesity-related subclinical risk factors
(e.g., borderline hypertension, impaired fasting glu-
cose, elevated liver enzymes, etc.), mild physical
symptoms (e.g., dyspnea on moderate exertion, occa-
sional aches and pains, fatigue, etc.), mild psy-
chopathology, mild functional limitations, and/or
mild impairment of well-being.
2. Presence of established obesity-related chronic disease
(e.g., hypertension, type 2 diabetes, sleep apnea,
osteoarthritis, reflux disease, polycystic ovary syn-
drome, anxiety disorder, etc.), moderate limitations in
activities of daily living and/or well-being.
3. Established end-organ damage such as myocardial
infarction, heart failure, diabetic complications, inca-
pacitating osteoarthritis, significant psychopathology,
significant functional limitations, and/or impairment of
well-being.
4. Severe (potentially end-stage) disabilities from obe-
sity-related chronic diseases, severe disabling
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psychopathology, severe functional limitations, and/or
severe impairment of well-being.
The EOSS has been validated as a system able to
identify patients at increased mortality risk who therefore
deserve more clinical and therapeutic attention [2].
We have taken advantage of this now well-established
staging system to develop a therapeutic algorithmic
chart (Fig. 1) that includes BMI, age and EOSS stages. At
each intersection, a color code identifies the proposed
preferred treatment option. Obviously, treatment options
are not mutually exclusive, but have to be understood as
additive (e.g., a patient eligible for bariatric surgery should
continue to follow therapeutic lifestyle changes and, if
needed, pharmacotherapy).
Strengths and limitations
The strength of the EOSS system relies on its ability to
better identify patients who are at increased risk of mor-
tality [2]. The limitations of the EOSS system have been
clearly highlighted by Sharma and Kushner in their review
paper [1]. They recognize that definitions of some risk
factors are subject to change. Furthermore, the EOSS
system includes subjective parameters, such as psycho-
logical impact or functional performance, the assessment of
which may vary among clinicians. In this regard, attention
should be drawn to the vagueness of certain definitions
such as mild psychopathology, anxiety disorder, significant
psychopathology, and severe disabling psychopathology.
In addition, the lack of any reference to eating disorders, in
particular binge eating disorder, should be pointed out
which since 2013 has been considered an autonomous
diagnostic category by DSM-5.
By integrating the EOSS system, our therapeutic algo-
rithmic chart includes its pros and cons. In addition, a
specific limitation of our chart is the lack of evidence-based
data.
Conclusion
We believe that chronic diseases such as obesity have to be
tackled with flexibility and understanding. Any treatment
option should be thoroughly explained to the patient,
sharing with him the rationale and cost–benefit ratio behind
any proposed treatment; treatment that has to be ultimately
tailored to the individual patient. However, any algorithm
that may help clinicians in their delicate choices is always
welcome. We hope this would be the case for our chart.
Finally, we did not indicate any level of evidence or
strength of recommendation, since the proposed chart is
based on expert opinions and since evidence is at the
moment insufficient.
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